Seock-Ah Im - Dissemin

Language
Login

All papers authored by Seock-Ah Im

This paper is made freely available by the publisher.

2024 Dennis J. Slamon

ORCID

, Véronique Diéras

ORCID

ORCID

, Nadia Harbeck

ORCID

, Seock-Ah Im

ORCID

, Karen A. Gelmon

ORCID

, Oleg N. Lipatov, Janice M. Walshe

ORCID

, Miguel Martin

ORCID

, Mariana Chavez-Macgregor

ORCID

, Eustratios Bananis, Eric Gauthier

ORCID

, Dongrui R. Lu

ORCID

, Sindy Kim, Richard S. Finn

ORCID

Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer

Download from doi.org

This paper is made freely available by the publisher.

Sara M. Tolaney

ORCID

, Elisabeth De Kermadec, Patrick Cohen

ORCID

ORCID

, Lei Wang, Seock-Ah Im

ORCID

Reply to Y. Yoshitomi et al

Download from doi.org

This paper is made freely available by the publisher.

2023 Sara M. Tolaney

ORCID

ORCID

, Katarina Petrakova, Suzette Delaloge

ORCID

, Mario Campone, Hiroji Iwata

ORCID

, Parvin F. Peddi

ORCID

, Peter A. Kaufman

ORCID

, Elisabeth De Kermadec, Qianying Liu, Patrick Cohen

ORCID

ORCID

, Lei Wang, Nils Ternès, Eric Boitier and 1 other authors

AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2022 Sherko Kuemmel

ORCID

, Mario Campone

ORCID

, Delphine Loirat, Rafael Lopez Lopez, J. Thaddeus Beck

ORCID

, Michelino De Laurentiis

ORCID

, Seock-Ah Im

ORCID

ORCID

ORCID

, Guenther G. Steger

ORCID

, Esther Zamora Adelantado

ORCID

, Francois P. Duhoux

ORCID

, Richard Greil, Irene Kuter

ORCID

ORCID

and 13 other authors

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

Upload

This paper is made freely available by the publisher.

2021 Yen-Shen Lu

ORCID

, Seock-Ah Im

ORCID

, Marco Colleoni

ORCID

, Fabio Franke, Aditya Bardia, Fatima Cardoso

ORCID

, Nadia Harbeck

ORCID

, Sara Hurvitz, Louis Chow, Joohyuk Sohn, Keun Seok Lee

ORCID

, Saul Campos-Gomez

ORCID

, Rafael Villanueva Vazquez, Kyung Hae Jung

ORCID

, K. Govind Babu and 13 other authors

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial

Download from aacrjournals.org

This paper is made freely available by the publisher.

Ian E. Krop

ORCID

, Seock-Ah Im

ORCID

, Carlos Barrios

ORCID

, Hervé Bonnefoi

ORCID

ORCID

ORCID

, Paul A. Ellis, Luca Gianni

ORCID

, Sandra M. Swain

ORCID

, Young-Hyuck Im, Michelino De Laurentiis

ORCID

, Zbigniew Nowecki

ORCID

, Chiun-Sheng Huang

ORCID

, Louis Fehrenbacher

ORCID

, Yoshinori Ito and 8 other authors

Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: The Phase III KAITLIN Study

Download from doi.org

This paper is made freely available by the publisher.

Sophie Cousin

ORCID

, Jean‐Yves Blay

ORCID

, Irene Braña Garcia, Johann S. de Bono, Christophe Le Tourneau, Victor Moreno, Jose Trigo, Christine L. Hann, Arun A. Azad

ORCID

, Seock‐Ah Im

ORCID

, Philippe A. Cassier, Christopher A. French, Antoine Italiano

ORCID

, Vicki L. Keedy, Ruth Plummer and 15 other authors

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Aditya Bardia, Fei Su, Nadia Solovieff, Seock-Ah Im

ORCID

ORCID

, Keun Seok Lee, Saul Campos-Gomez

ORCID

, Kyung Hae Jung, Marco Colleoni, Rafael Villanueva Vázquez, Fabio Franke, Sara Hurvitz

ORCID

, Nadia Harbeck

ORCID

, Louis Chow, Tetiana Taran and 5 other authors

Genomic Profiling of Premenopausal HR+ and HER2– Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclib

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Simon J. Dovedi, Matthew J. Elder, Chunning Yang, Suzanne I. Sitnikova, Lorraine Irving

ORCID

, Anna Hansen, James Hair, Des C. Jones, Sumati Hasani

ORCID

, Bo Wang, Seock-Ah Im

ORCID

, Ben Tran, Deepa S. Subramaniam, Shelby D. Gainer, Kapil Vashisht and 20 other authors

Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 Mark Robson

ORCID

, Kathryn J. Ruddy

ORCID

, Seock-Ah Im

ORCID

, Elżbieta Senkus

ORCID

, Binghe Xu, Susan M. Domchek, Norikazu Masuda, Wei Li, Nadine Tung, Anne Armstrong, Suzette Delaloge, Wendy Bannister, Carsten Goessl, Arnold Degboe, Robert Hettle and 1 other authors

Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Seung Hyuck Jeon

ORCID

ORCID

, Yi-Jun Kim, Kyung-Hun Lee

ORCID

, Hyun-Seob Lee

ORCID

, Min Jung Kim, Seock-Ah Im

ORCID

ORCID

, Tae-You Kim

Targeted next-generation DNA sequencing identifies Notch signaling pathway mutation as a predictor of radiation response

Upload

This paper is available in a repository.

2018 Costanza Paoletti, Gaia Schiavon, Emily M. Dolce, Elizabeth P. Darga, Thomas Hedley Carr

ORCID

, Joseph Geradts, Matthias Hoch, Teresa Klinowska, Justin P. O. Lindemann, Gayle Marshall, Shethah Morgan, Parul Patel, Vicky Rowlands, Nitharsan Sathiyayogan, Kimberly Aung and 12 other authors

Circulating biomarkers and resistance to endocrine therapy in metastatic breast cancers: correlative results from AZD9496 oral SERD phase I trial.

Download from clincancerres.aacrjournals.org

This paper is made freely available by the publisher.

X. Pivot

ORCID

, I. Bondarenko

ORCID

, Z. Nowecki, M. Dvorkin, E. Trishkina, J.-H. Ahn, S.-A. Im

ORCID

ORCID

, S. Chatterjee, M. Z. Wojtukiewicz, Y. Shparyk, V. Moiseyenko, M. Bello, V. Semiglazov, Y. Lee and 1 other authors

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results

Download from doi.org

This paper is made freely available by the publisher.

Hope S. Rugo, Jean-Pierre Delord, Seock-Ah Im

ORCID

, Patrick A. Ott, Sarina A. Piha-Paul

ORCID

, Philippe L. Bedard, Jasgit Sachdev, Christophe Le Tourneau, Emilie M. J. van Brummelen, Andrea Varga, Roberto Salgado, Sherene Loi, Sanatan Saraf, Dina Pietrangelo, Vassiliki Karantza and 1 other authors

Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Download from aacrjournals.org

Missing publications? Search for publications with a matching author name.